[Immunohistochemical study on the expression of copper and zinc-superoxide dismutase (Cu, Zn-SOD) in human adenohypophysis and pituitary adenomas]
- PMID: 7826710
[Immunohistochemical study on the expression of copper and zinc-superoxide dismutase (Cu, Zn-SOD) in human adenohypophysis and pituitary adenomas]
Abstract
A location of copper and zinc- superoxide dismutase (Cu, Zn-SOD) in adenohypophysis and pituitary adenomas was examined with immunohistochemical technique. Pituitary adenomas include thirteen functioning, five nonfunctioning; functioning adenomas consist seven prolactinomas, four growth hormone (GH) secreting, two adrenocorticotropic hormone (ACTH) secreting adenomas. Three specimens of normal adenohypophysis were used for control study. The Cu, Zn-SOD was localized diffusely in the cytoplasm of normal adenohypophyseal cells and the tumor cells. Sometimes immunoreactive products of Cu, Zn-SOD revealed in the cytoplasm of endothelial cell, neutrophil, macrophage and the cell membrane of erythrocyte in the vessels. The content of Cu, Zn-SOD in normal adenohypophyseal cells and pituitary adenomas was markedly higher in normal cells than adenoma cells. No significant difference of the SOD content was observed not only in non-functioning adenoma but also in functioning adenoma cells including PRL, GH and ACTH cells.
Similar articles
-
Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.Agents Actions Suppl. 1992;38 ( Pt 2):175-82. Agents Actions Suppl. 1992. PMID: 1462825
-
Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.Am J Pathol. 1989 Mar;134(3):605-13. Am J Pathol. 1989. PMID: 2466405 Free PMC article.
-
Immunocytochemical demonstration of the expression and induction of manganese-superoxide dismutase in the adenohypophysis.Histochem J. 1998 Apr;30(4):231-6. doi: 10.1023/a:1003203721432. Histochem J. 1998. PMID: 9610813
-
Expression of cathepsin B and cystatin C in the human adenohypophysis and in pituitary adenomas.Oncol Rep. 2000 Jan-Feb;7(1):27-31. Oncol Rep. 2000. PMID: 10601586
-
Plurihormonal pituitary adenoma with concomitant adrenocorticotropic hormone (ACTH) and growth hormone (GH) secretion: a report of two cases and review of the literature.Acta Neurochir (Wien). 2014 Jan;156(1):141-6. doi: 10.1007/s00701-013-1890-y. Epub 2013 Oct 1. Acta Neurochir (Wien). 2014. PMID: 24081787 Review.
Cited by
-
Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas.Front Pharmacol. 2021 Mar 24;12:565748. doi: 10.3389/fphar.2021.565748. eCollection 2021. Front Pharmacol. 2021. PMID: 33841137 Free PMC article.
-
Signaling pathway networks mined from human pituitary adenoma proteomics data.BMC Med Genomics. 2010 Apr 28;3:13. doi: 10.1186/1755-8794-3-13. BMC Med Genomics. 2010. PMID: 20426862 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical